The pitch to investors centered on Virgin Australia as a strong, profitable No. 2 player happy to focus primarily on domestic ...

Brentwood, Tenn.-based Surgery Partners, one of the country’s largest ASC operators, rejected a buyout bid from Bain Capital, its largest shareholder, choosing to remain independent. Bain Capital, ...

Surgery Partners, Inc. declines Bain Capital's $25.75/share offer, citing growth potential. Click for my updated look at SGRY ...

A recent Bloomberg report said the deal is worth nearly $4 billion. Not happening, however, is Bain Capital buying all of ...

Detailed price information for Surgery Partners CS (SGRY-Q) from The Globe and Mail including charting and trades.

Recent news in the health sector includes Surgery Partners' rejection of Bain Capital's take-private offer, Purdue Pharma's ...

Recent health headlines spotlight Surgery Partners rejecting Bain Capital's offer, the U.S. betting on China's drug potential ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Surgery Partners said on Tuesday it was unable to agree to the terms set by Bain Capital, its largest shareholder, to take the surgical facility operator private.

Surgery Partners rejects Bain Capital's offer, choosing to stay public. Here's why the local company said no and the future ...

Brentwood, Tenn.-based Surgery Partners has rejected a proposal from private equity firm Bain Capital to acquire all outstanding shares not already owned by the firm, reaffirming its commitment to ...

Surgery Partners said on Tuesday it was unable to agree to the terms set by Bain Capital, its largest shareholder, to take ...